Patricia (Patty) Martin is the former CEO of BioCrossroads and former Eli Lilly and Company executive, where she served as chief operating officer (COO) of Lilly Diabetes as well Lilly’s Chief Diversity Officer (CDO) and Chief Alliance Officer (CAO). In her 25-year career at Lilly, she also had leadership roles that included strategy, clinical product development, and investor relations. Martin’s background is a unique breadth of experience integrating science and business. As COO of Lilly Diabetes, she was part of a leadership team that established a vision and strategy that uniquely addressed the increased prevalence and diverse needs of people living with diabetes. As CAO, she spearheaded collaborative efforts to ensure the success of Lilly’s partnerships and facilitated cross-functional and cross-disciplinary cooperation to deliver results. Martin serves on the board of directors of CareSource, Inc., AN2 Therapeutics, and UltiMed, Inc. Actively involved in Indianapolis and national non-profit organizations, she is currently a member of the Indiana University Women’s Philanthropy Leadership Council; member of the board of the Regenstrief Institute; Member of Board of CareSource; the Dean’s Advisory Council for the Indiana University Kelley School of Business; and was the board chair for the 500 Festival in 2016.